# Evaluation of Efficacy and Safety of THRV-1268 in Long QT Syndrome Type 2 (LQTS 2)

> clinical trial · VERIFIED · 2026-07-22

Status: RECRUITING · Sponsor: Thryv Therapeutics, Inc. · Condition: Long QT Syndrome (LQTS) 2

- Company: Thryv Therapeutics, Inc.
- Sector: Long QT Syndrome (LQTS) 2
- Primary source: https://clinicaltrials.gov/study/NCT07277582

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.